Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

SMARTBREAKER

Financiado

Cerrado

Rational designing of new meganucleases as molecular scissors for genomic tailor...

Rational designing of new meganucleases as molecular scissors for genomic tailoring "Regenerative medicine using gene targeting by homologous recombination is one of the most powerful methods to achieve precise genome modifications. In the absence of double strand breaks the frequency of homologues recombination... ver más

30/06/2014

FUNDACION SECTOR P...

75K€

Presupuesto del proyecto: 75K€

Líder del proyecto

FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIO... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5 | 18M€

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2014-06-30 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

FUNDACION SECTOR PUBLICO EST...

0.00€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

DMONICKASEDESIGN Safer gene repair and targeting based on the monomeric megan... 155K€ Cerrado

BES-2010-036479 POLIMERASAS QUE REPARAN ROTURAS DE DOBLE CADENA EN EL DNA 43K€ Cerrado

RE-GENESis GENome Editing and delivery Strategies for REcoding the mamm... 225K€ Cerrado

GT-SKIN Gene Therapy for Inherited Skin Adhesion Disorders 2M€ Cerrado

BIO2013-50068-EXP DESARROLLO DE UN NUEVO SISTEMA PARA UNA FACIL EDICION DE GEN... 73K€ Cerrado

ZINC-HUBS Engineering zinc fingers to target cancer hub genes 1M€ Cerrado

Líder del proyecto

FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIO... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5 | 18M€

Presupuesto del proyecto 75K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "Regenerative medicine using gene targeting by homologous recombination is one of the most powerful methods to achieve precise genome modifications. In the absence of double strand breaks the frequency of homologues recombination events at a target site is very low. A wide range of molecular tools are used to achieve targeting double strand breaks to increase the efficiency of homologues recombination. Meganucleases are a class of homing endonucleases that can recognize long DNA sequences with high specificity. This characteristic makes them one of the most promising tools to promote specific double strand breaks. Therefore the design of meganucleases able to recognize new DNA targets is emerging as a crucial area in the regenerative medicine. The huge effort of several labs has contributed to improve the designing process of new meganucleases. However, additonal efforts are urgently needed to understand the full potential of these proteins. The aim of this project is at first to deliver a more rational way to design meganucleases with new DNA specificity by incorporating in the designing stage DNA sequence-depended features that recently have been showed to influence protein binding, then deliver a library of engineered meganucleases able to recognize sequences of clinical interest and finally deliver new reagents to introduce such enzymes into iPS cells. All the findings will contribute to identify a potential new way to cure monogenic diseases and also build the bases to new therapeutic approach for multigenic disorder such as some types of leukemias and lymphomas. As a reintegration program and because of the collaborative nature of the proposal this action will support the candidate in returning to Europe and to take part in a new, vibrant and cutting-edge research field. The candidate will contribute to European research by using all the knowledge he has acquired during his experience in the USA."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores